| Literature DB >> 30150508 |
Hyun Bong Park1,2, Nguyen Quoc Tuan3,4, Joonseok Oh5,6, Younglim Son7, Mark T Hamann8, Robert Stone9, Michelle Kelly10, Sangtaek Oh11, MinKyun Na12.
Abstract
The Wnt/β-catenin signaling pathway is known to play critical roles in a wide range of cellular processes: cell proliferation, differentiation, migration and embryonic development. Importantly, dysregulation of this pathway is tightly associated with pathogenesis in most human cancers. Therefore, the Wnt/β-catenin pathway has emerged as a promising target in anticancer drug screening programs. In the present study, we have isolated three previously unreported metabolites from an undescribed sponge, a species of Monanchora (Order Poecilosclerida, Family Crambidae), closely related to the northeastern Pacific species Monanchora pulchra, collected from deep waters off the Aleutian Islands of Alaska. Through an assortment of NMR, MS, ECD, computational chemical shifts calculation, and DP4, chemical structures of these metabolites have been characterized as spirocyclic ring-containing sesterterpenoid (1) and cholestane-type steroidal analogues (2 and 3). These compounds exhibited the inhibition of β-catenin response transcription (CRT) through the promotion of β-catenin degradation, which was in part implicated in the antiproliferative activity against two CRT-positive colon cancer cell lines.Entities:
Keywords: Alaska; Wnt; colorectal cancer; marine sponge; natural products; sesterterpenoid; steroid; β-catenin
Mesh:
Substances:
Year: 2018 PMID: 30150508 PMCID: PMC6164309 DOI: 10.3390/md16090297
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Chemical structures of 1–3.
1H and 13C NMR data of 1 (CDCl3, 600 and 150 MHz).
| No. | ||||
|---|---|---|---|---|
| 1 | 63.0 | CH | 4.47 | dd, 4.7, 3.0 |
| 2 | 139.4 | CH | 6.62 | dd, 5.9, 1.6 |
| 3 | 139.5 | C | ||
| 4 | 198.8 | C | ||
| 5 | 38.0 | CH2 | 2.59 | dd, 13.7, 2.6 |
| 2.49 | m | |||
| 6 | 33.3 | CH | 2.54 | m |
| 7 | 142.5 | C | ||
| 8 | 125.1 | CH | 5.66 | s |
| 9 | 96.8 | C | ||
| 10 | 44.5 | CH2 | 2.32 | dd, 13.4, 1.5 |
| 1.87 | m a | |||
| 11 | 80.1 | C | ||
| 12 | 42.5 | CH2 | 2.15 | brd, 13.2 |
| 1.76 | m a | |||
| 13 | 65.1 | CH | 4.65 | m |
| 14 | 125.2 | CH | 5.25 | d, 7.6 |
| 15 | 139.0 | C | ||
| 16 | 42.9 | CH2 | 2.80 | m |
| 17 | 127.5 | CH | 5.61 | m |
| 18 | 135.2 | CH | 6.15 | d, 15.6 |
| 19 | 142.1 | C | ||
| 20 | 115.3 | CH2 | 4.90 | d, 5.2 |
| 21 | 16.1 | CH3 | 1.86 | s |
| 22 | 63.8 | CH2 | 4.12 | m |
| 23 | 24.6 | CH3 | 1.78 | s |
| 24 | 17.0 | CH3 | 1.74 | s |
| 25 | 18.9 | CH3 | 1.84 | s |
| 26 | 170.3 | C | ||
| 27 | 22.6 | CH3 | 1.96 | s |
a overlapping signal.
Figure 2(A) Key COSY and HMBC correlations, (B) Key NOESY correlations, (C) Overlay of calculated (B3LYP/6-31G(d,p)) and experimental ECD spectra of 1.
1H and 13C NMR data of 2 and 3 (CDCl3, 600 and 150 MHz).
| No. | 2 | 3 | ||||||
|---|---|---|---|---|---|---|---|---|
| 1 | 35.8 | CH2 | 2.02 | ddd, 13.4, 5.1, 3.2 | 35.8 | CH2 | 2.01 | m |
| 1.67 | m a | 1.68 | m | |||||
| 2 | 33.1 | CH2 | 2.40 | dd, 14.6, 5.1 | 34.1 | CH2 | 2.41 | m |
| 2.28 | ddd, 14.6, 4.3, 2.5 | 2.34 | m | |||||
| 3 | 199.8 | C | 199.7 | C | ||||
| 4 | 124.0 | CH | 5.73 | s | 124.1 | CH | 5.74 | s |
| 5 | 171.6 | C | 171.1 | C | ||||
| 6 | 34.1 | CH2 | 2.43 | m a | 32.9 | CH2 | 2.40 | m |
| 2.36 | dt, 17.0, 3.8 | 2.27 | m | |||||
| 7 | 32.1 | CH2 | 1.84 | m a | 32.0 | CH2 | 1.83 | m |
| 1.03 | dd, 12.7, 3.3 | 1.00 | m | |||||
| 8 | 35.9 | CH | 1.52 | m a | 34.7 | CH | 1.65 | m |
| 9 | 54.2 | CH | 0.94 | m a | 54.0 | CH | 0.93 | m |
| 10 | 38.8 | C | 38.7 | C | ||||
| 11 | 21.1 | CH2 | 1.58 | m a | 20.9 | CH2 | 1.52 | m |
| 1.42 | dd, 13.0, 4.0 | |||||||
| 12 | 38.5 | CH2 | 1.84 | m a | 40.4 | CH2 | 2.17 | m |
| 1.17 | m a | 1.17 | m | |||||
| 13 | 44.0 | C | 43.1 | C | ||||
| 14 | 55.5 | CH | 1.08 | m a | 53.9 | CH | 0.87 | m |
| 15 | 24.4 | CH2 | 1.73 | m a | 37.5 | CH2 | 2.27 | m |
| 1.23 | m a | 1.34 | m | |||||
| 16 | 24.8 | CH2 | 1.84 | m a | 74.2 | CH | 4.65 | m |
| 17 | 59.1 | CH | 2.08 | t, 9.5 | 60.6 | CH | 1.25 | m |
| 18 | 13.4 | CH3 | 0.63 | s | 15.1 | CH3 | 1.21 | s |
| 19 | 17.6 | CH3 | 1.18 | s | 17.5 | CH3 | 1.21 | s |
| 20 | 138.5 | C | 76.5 | C | ||||
| 21 | 17.8 | CH3 | 1.70 | s | 26.7 | CH3 | 1.32 | s |
| 22 | 128.1 | CH | 5.24 | d, 8.8 | 42.6 | CH2 | 1.68 | m |
| 23 | 73.7 | CH | 4.15 | dd, 8.8, 6.7 | 28.7 | CH2 | 2.03 | m |
| 24 | 34.7 | CH | 1.70 | m a | 156.3 | C | ||
| 25 | 18.5 | CH3 | 0.96 | d, 6.7 | 33.9 | CH | 2.23 | m |
| 26 | 18.3 | CH3 | 0.88 | d, 6.7 | 22.1 | CH3 | 1.03 | d, 7.0 |
| 27 | 22.1 | CH3 | 1.03 | d, 7.0 | ||||
| 28 | 106.5 | CH2 | 4.75 | brs | ||||
| 4.68 | s | |||||||
a overlapping resonances.
Figure 3Key COSY, HMBC and NOE correlations of 2 (A) and 3 (B).
Figure 4DP4 probabilities for 2 (A) and 3 (B).
Figure 5The effect of 1, 2, and 3 on the Wnt/β-catenin pathway. (A) HEK293-FL reporter cells were incubated with 1–3 in the presence of Wnt3a-CM for 15 h and luciferase activity was determined. (B) Cytosolic proteins were prepared from HEK293-FL reporter cells treated with the vehicle or 1–3 in the presence of Wnt3a-CM for 15 h and subjected to western blotting.
Figure 6The effect of 1, 2, and 3 on the viability of CRT-positive colon cancer cells. the Wnt/β-catenin pathway. HCT116 and SW480 colon cancer cells were incubated with different concentrations of 1–3 for 48 h and cell viability was determined by Cell-Titer-Glo assay.